SOPHiA GENETICS (SOPH) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SOPHiA GENETICS has announced strategic leadership changes with Ross Muken promoted to President and George Cardoza appointed as the new Chief Financial Officer. Muken, who has been with the company since 2021, will now oversee global operations and strategic planning. Cardoza brings over 30 years of financial expertise in precision medicine, poised to strengthen SOPHiA GENETICS’ growth trajectory.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.